Early stool microbiome and metabolome signatures in pediatric patients undergoing allogeneic hematopoietic cell transplantation.
Caitlin W ElgartenCeylan TanesJung-Jin LeeLara A Danziger-IsakovMichael S GrimleyMichael GreenMarian G MichaelsJessie L BarnumMonica I ArduraJeffrey J AulettaJesse BlumenstockAlix E SeifKyle L BittingerBrian T FisherPublished in: Pediatric blood & cancer (2021)
Stool samples from pediatric allogeneic HCT patients demonstrate substantial dysbiosis early in the transplant course. As microbiome disruptions associate with adverse transplant outcomes, pediatric-specific analyses examining longitudinal microbiome and metabolome changes are imperative to identify causal associations and to inform rational design of interventions.
Keyphrases
- stem cell transplantation
- patients undergoing
- end stage renal disease
- bone marrow
- newly diagnosed
- ejection fraction
- chronic kidney disease
- peritoneal dialysis
- prognostic factors
- physical activity
- gene expression
- hematopoietic stem cell
- emergency department
- dna methylation
- genome wide
- adipose tissue
- young adults
- skeletal muscle
- cross sectional
- cell death